ESOCF(ESOCF)
ESOCF
No analyst ratings available
No analyst price targets available for ESOCF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $81.24B | $82.40B | $83.75B | $80.43B | $85.93B |
| Low | $70.37B | $67.94B | $70.78B | $67.98B | $72.62B |
| High | $109.50B | $109.95B | $112.30B | $107.86B | $115.22B |
| EBITDA Avg | $16.15B | $16.38B | $16.64B | $15.99B | $17.08B |
| Low | $13.99B | $13.50B | $14.07B | $13.51B | $14.43B |
| High | $21.76B | $21.85B | $22.32B | $21.44B | $22.90B |
| EBIT Avg | $10.65B | $10.80B | $10.98B | $10.54B | $11.26B |
| Low | $9.22B | $8.91B | $9.28B | $8.91B | $9.52B |
| High | $14.35B | $14.41B | $14.72B | $14.14B | $15.10B |
| Net Income Avg | $7.76B | $8.08B | $8.49B | $8.60B | $8.65B |
| Low | $6.20B | $6.45B | $6.78B | $6.86B | $6.91B |
| High | $11.20B | $11.66B | $12.25B | $12.41B | $12.49B |
| EPS Avg | $0.72 | $0.75 | $0.78 | $0.79 | $0.80 |
| Low | $0.57 | $0.60 | $0.63 | $0.63 | $0.64 |
| High | $1.03 | $1.08 | $1.13 | $1.15 | $1.15 |
| Analysts (Rev / EPS) | 21 / 1 | 21 / 1 | 18 / 1 | 10 / 1 | 10 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $22.01B | $26.85B |
| Low | $20.06B | $24.47B |
| High | $23.96B | $29.22B |
| EBITDA Avg | $4.37B | $5.34B |
| Low | $3.99B | $4.86B |
| High | $4.76B | $5.81B |
| EBIT Avg | $2.89B | $3.52B |
| Low | $2.63B | $3.21B |
| High | $3.14B | $3.83B |
| Net Income Avg | $1.87B | $1.79B |
| Low | $1.65B | $1.59B |
| High | $2.08B | $2.00B |
| EPS Avg | $0.18 | $0.17 |
| Low | $0.16 | $0.15 |
| High | $0.20 | $0.19 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 |